revel x semaglutide When it comes to GLP-1

In adherence with the Boehringer Ingelheim Policy on Transparency and Publication of Clinical Study Data, scientific and medical researchers can request access to clinical study data after publication of the primary manuscript and secondary analyses in peer-reviewed journals and regulatory and reimbursement activities are completed, normally within 1 year after the marketing application has been granted by major regulatory authorities

Real science, real results.* Subscribe & Save 20%

One of these studies initially found significant positive correlation between fasting ghrelin levels and activity in the left inferior occipital gyrus and right superior occipital gyrus, but these results did not survive outlier correction (Wever et al., 2021)

Additionally, the drug reduces the risk of heart attack, stroke, and premature death in people with type 2 diabetes and heart disease, significantly improving overall health outcomes

In the STEP 2 study, where patients also had type 2 diabetes, cardiovascular events occurred in 6% of semaglutide patients and 3% of placebo patients